Lumbar total disc replacement and fusion provide similar clinical outcomes at 5 years .
This report has been verified
by one or more authors of the
original publication.
Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative di
J Neurosurg Spine. 2012 Oct 19236 patients with degenerative disc disease were randomized to receive the ProDisc-L total disc replacement or circumferential fusion. The results of the 5 year study indicate that total disc replacement is non-inferior to fusion and results in significantly better short-term outcomes for some measures including satisfaction. Both fusion and total disc replacement are reasonable long-term surgical options for patients with degenerative disc disease.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
